Cambridge UK: 25 February 2019 - Lonza Biologics becomes the latest One Nucleus Partner. The Partner Program is tailor-made to meet the needs both of the Partner and the interests of One Nucleus members.Sarah Holland, Global Head of Licensing at Lonza commented ‘Lonza has been a member of the One Nucleus ecosystem for a number of years. We are delighted to strengthen our relationship further by becoming a One Nucleus partner. We are committed to supporting innovation and see the building of strong relationships with biotechnology companies and research institutes as a key part of our…
18 February 2019 – Oxford: Oxford Genetics and Sphere Fluidics announce a multi-partner collaboration to expedite the development of automated microfluidic systems for rapid and high-throughput gene editing in mammalian cell lines.
Under the agreement, Sphere Fluidics will act as the lead partner, looking to utilise its extensive expertise in microfluidic systems to produce new products designed to meet the requirements of multiplexed gene editing workflows.
Oxford Genetics and the University of Edinburgh will provide input into industrial and application specific requirements, both in…
Boyds, a leading consultancy business supporting the development of pharmaceutical and biotech products for patient benefit, has announced a key appointment in support of its continued growth plans.
Dr Sabine Rühle joins Boyds as Senior Associate of Regulatory Affairs and will be based at Boyds’ Cambridge offices, which opened last year.
A member of the Organisation of Professionals in Regulatory Affairs (MTOPRA), Sabine joins from Pharmaceutical Product Development, where she was Senior Regulatory Affairs Specialist and coordinated global CTA submissions for a variety of products and…
PRINCETON, NJ – Feb. 21, 2019 – Certara®, the global leader in model-informed drug development, regulatory science, real-world evidence and market access services, today announced the launch of version 19.1 of its flagship scientific informatics platform D360. D360 v19.1 expands the platform’s capabilities for biologists and biologics scientists, deepens support for small molecule chemistry, and provides workflow enhancements based on community feedback. This latest version of D360 takes its name from its calendar release date; this is the first new release in 2019.
The role of drug discovery…
Cambridge, UK, and Shanghai, China, February 20 2019: Owlstone Medical Ltd., a global diagnostics company developing a breathalyzer for applications in early disease detection and precision medicine, and Renji Hospital, today announced a collaboration to conduct a clinical trial into the early detection of lung cancer with support from the Li Ka Shing Foundation.
Recognizing the escalating incidence of lung cancer in China, Owlstone Medical and Renji Hospital have a mutual interest in developing and making accessible diagnostics for the early detection of disease, which can result in the…
Boyds, a leading consultancy business supporting the development of pharmaceutical and biotech products and devices for patient benefit, has established an office facility at Alderley Park as part of continued growth plans.
Boyds, which has headquarters in Crewe, and has recently expanded into new premises in Cambridge and Dublin, now employs 20 members of staff.
Alderley Park, a development by Bruntwood SciTech, is home to the internationally-recognised Mereside bioscience campus which offers more than 1m sq ft of high specification lab space, a range of scientific services and the Alderley…
Super-fast product addresses critical unmet need in development of next generation
artificial pancreas systems”
“Novel formulation significantly accelerates absorption of insulin post injection - accelerating the onset of glucose lowering.”
Arecor Ltd (“the Company”), the specialty pharmaceutical company leveraging its innovative and proprietary formulation technology to develop superior treatments for a range of disease areas, including diabetes, is pleased to announce that the Company has been awarded a £0.5 million grant from Innovate UK, the UK’s innovation agency, to advance the Company…
How can you use technology to your business advantage and design your brand to succeed in a world where the consumer now seems to hold all the power? A day-long forum on Friday 22nd March, Tech for Empowerment, gives Cambridge companies the opportunity to find out from global thought leaders - and to promote their own tech solutions by exhibiting at the event.
Customers don’t buy brands. They join brands. They want a vote in what gets produced and how it gets delivered. They’re willing to roll up their sleeves and help out — not only by promoting the brand to their friends, but by…
If you're looking for a job or a change of career direction, don't miss the opportunity to meet some of the region's most exciting technology companies at Cambridge Network's next Recruitment Evening on Tuesday 26 February.
This - the latest in a series of popular events that bring together potential candidates and leading employers keen to find talent - takes place at the Postdoc Centre, Eddington (next to Madingley Road Park & Ride) from 6pm - 9pm.
It will feature a mix of companies showcasing their job vacancies from exhibition stands, and several useful workshops.…
Boyds, a leading consultancy business supporting the development of pharmaceutical and biotech products for patient benefit, has opened an office in Dublin, Ireland in a step that will ensure the continuity of service to its clients once the UK leaves the EU on 29th March.
Boyds, which has headquarters in Crewe, and expanded into new premises outside Cambridge early last year, now employs 20 members of staff.
The new office will be based at DCU Invent on the Dublin City University Campus.
Professor Alan Boyd, Founder and CEO of Boyds, commented: “The UK’s departure from the EU has significant…